Acureomics AB offers metabolic profiling in the pharmaceutical, biotechnology and food industries. These fields hold enormous potential for enhancing the drug discovery and development processes in the pharmaceutical industry and opening up new possibilities for diagnostic approaches and personalized medicine in the healthcare field.
Simultaneous development of therapeutic, diagnostic or prognostic biomarkers is particularly advantageous for evaluation of clinical trials and for more individual-based, personalized healthcare. Acureomics has several projects and collaborations to find novel indicators for various diseases. The following services are provided by Acureomics:
• Study design and execution of metabolomics studies
• Access to cutting-edge metabolomics MS analysis
• Multivariate data analysis and statistical modeling to provide validated insights into the complex biochemical processes in disease, diagnosis, treatment and prognosis
Contact details
ceo@acureomics.com
